Targeted delivery of anticancer drugs to tumor vessels by use of liposomes modified with a peptide identified by phage biopanning with human endothelial progenitor cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International journal of pharmaceutics

• Publication date

  2017-05-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2017.03.059PMID 28359814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneity of tumor endothelial cells and drug delivery.

  2016cited by this paper
• Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin.

  2015cited by this paper
• Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry.

  2015cited by this paper
• Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.

  2015cited by this paper
• Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499.

  2014cited by this paper
• MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells.

  2013cited by this paper
• Anti-angiogenesis therapy in cancer: current challenges and future perspectives.

  2012cited by this paper
• Doxil®--the first FDA-approved nano-drug: lessons learned.

  2012cited by this paper
• Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.

  2012cited by this paper
• Tumor angiogenesis: molecular pathways and therapeutic targets

  2011cited by this paper
• Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78

  2010cited by this paper
• Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.

  2009cited by this paper
• Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression.

  2009cited by this paper
• Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis

  2008cited by this paper
• Antineovascular therapy with angiogenic vessel‐targeted polyethyleneglycol‐shielded liposomal DPP–CNDAC

  2008cited by this paper
• Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248

  2008cited by this paper
• Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer

  2007cited by this paper
• Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

  2007cited by this paper
• Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer.

  2006cited by this paper
• Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.

  2006cited by this paper
• Antineovascular therapy, a novel antiangiogenic approach

  2005cited by this paper
• Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

  2005cited by this paper
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

  2005cited by this paper
• Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

  2004cited by this paper
• Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.

  2004cited by this paper
• Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.

  2003cited by this paper
• Anti-neovascular therapy using novel peptides homing to angiogenic vessels

  2002cited by this paper
• Anti‐neovascular therapy by liposomal DPP‐CNDAC targeted to angiogenic vessels

  2002cited by this paper
• Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

  2001cited by this paper
• Photodynamic therapy targeted to tumor-induced angiogenic vessels.

  2001cited by this paper
• Genes expressed in human tumor endothelium.

  2000cited by this paper
• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

  2000cited by this paper
• Tumor angiogenesis—new drugs on the block

  1999cited by this paper
• Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

  1999cited by this paper
• αv Integrins as receptors for tumor targeting by circulating ligands

  1997cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

  1990cited by this paper

• On the origin of non-specific binders isolated in the selection of phage display peptide libraries

  2025cites this paper
• Scalable Preparation of Extracellular Vesicles Encapsulating Anticancer Drugs by High-Pressure Homogenization for Targeted Cancer Therapy.

  2025cites this paper
• A Beautiful Bind: Phage Display and the Search for Cell-Selective Peptides

  2025cites this paper
• Empowering Healthcare with Phage Display Technology.

  2025cites this paper
• Liposomes in the cosmetics: present and outlook

  2024cites this paper
• Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance

  2024cites this paper
• The Next Generation of Drug Delivery: Harnessing the Power of Bacteriophages.

  2024cites this paper
• Current Therapeutic Approaches and Promising Perspectives of Using Bioengineered Peptides in Fighting Chemoresistance in Triple-Negative Breast Cancer.

  2023cites this paper
• Applications of the phage display technology in molecular biology, biotechnology and medicine

  2023cites this paper
• Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions

  2023cites this paper
• One-Step Pharmaceutical Preparation of PEG-Modified Exosomes Encapsulating Anti-Cancer Drugs by a High-Pressure Homogenization Technique

  2023cites this paper
• Multifunctional Patented Nanotherapeutics for Cancer Intervention: 2010-onwards.

  2022cites this paper
• Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke

  2022cites this paper
• Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era

  2022cites this paper
• Exploring phage engineering to advance nanobiotechnology

  2022cites this paper
• Development of a Low-Molecular-Weight Aβ42 Detection System Using a Enzyme-Linked Peptide Assay

  2021cites this paper
• Nanocarriers for Biomedicine: From Lipid Formulations to Inorganic and Hybrid Nanoparticles

  2021cites this paper
• Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer

  2021cites this paper
• Development of peptide aptamers as alternatives for antibody in the detection of amyloid-beta 42 aggregates.

  2020cites this paper
• Leukocyte-mimetic liposomes penetrate into tumor spheroids and suppress spheroid growth by encapsulated doxorubicin.

  2020cites this paper
• Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.

  2019cites this paper
• Liposomes Conjugated with a Pilot Molecule

  2019cites this paper
• Targeting Tumor Endothelial Cells with Nanoparticles

  2019cites this paper
• Peptide ligand-mediated targeted drug delivery of nanomedicines.

  2019cites this paper
• In Vivo Translation of Peptide-Targeted Drug Delivery Systems Discovered by Phage Display.

  2018cites this paper
• The Improved Delivery to Breast Cancer Based on a Novel Nanocarrier Modified with High‐Affinity Peptides Discovered by Phage Display

  2018cites this paper
• Improved oral bioavailability of notoginsenoside R1 with sodium glycocholate‐mediated liposomes: Preparation by supercritical fluid technology and evaluation in vitro and in vivo

  2018cites this paper
• Phage display: an important tool in the discovery of peptides with anti-HIV activity.

  2018cites this paper